BioCentury
ARTICLE | Company News

Adolor neurology, gastrointestinal news

July 26, 2010 7:00 AM UTC

Adolor, which had $62.3 million in cash at June 30, expects the restructuring to give it sufficient cash to fund operations through 2012. At March 31, Adolor had a three-month operating loss of $9.7 m...